
Implantable Cardioverter Defibrillators Market by Implantation Location (Subcutaneous Implantable Cardioverter Defibrillator, Transvenous Implantable Cardioverter Defibrillator), Product (Biventricular/Cardiac Resynchronization Therapy Defibrillators, Dua
Description
Implantable Cardioverter Defibrillators Market by Implantation Location (Subcutaneous Implantable Cardioverter Defibrillator, Transvenous Implantable Cardioverter Defibrillator), Product (Biventricular/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICD, Single-Chamber ICD), End User - Global Forecast 2024-2030
The Implantable Cardioverter Defibrillators Market size was estimated at USD 4.50 billion in 2023 and expected to reach USD 4.73 billion in 2024, at a CAGR 5.91% to reach USD 6.73 billion by 2030.
Global Implantable Cardioverter Defibrillators Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Implantable Cardioverter Defibrillators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Implantable Cardioverter Defibrillators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Implantable Cardioverter Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtaCor Medical, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova plc, Medtronic plc, and MicroPort Scientific Corporation.
Market Segmentation & Coverage
This research report categorizes the Implantable Cardioverter Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:
Implantation Location
Subcutaneous Implantable Cardioverter Defibrillator
Transvenous Implantable Cardioverter Defibrillator
Product
Biventricular/Cardiac Resynchronization Therapy Defibrillators
Dual-Chamber ICD
Single-Chamber ICD
End User
Ambulatory Care Unit
Cardiac Center
Electrophysiology Laboratory
Home Care Setting
Hospital & Clinic
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Implantable Cardioverter Defibrillators Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Implantable Cardioverter Defibrillators Market?
3. What are the technology trends and regulatory frameworks in the Implantable Cardioverter Defibrillators Market?
4. What is the market share of the leading vendors in the Implantable Cardioverter Defibrillators Market?
5. Which modes and strategic moves are suitable for entering the Implantable Cardioverter Defibrillators Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
192 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Implantable Cardioverter Defibrillators Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing aging population for cardiovascular diseases and rising awareness about advantages of ICD devices
- 5.1.1.2. Effective in treating sudden cardiac arrest caused due to cardiac arrhythmias, ventricular fibrillation and pulseless ventricular tachycardia
- 5.1.1.3. Increasing number of training and awareness programs across the globe for ICDs
- 5.1.2. Restraints
- 5.1.2.1. Associated technical issues with noticeable incidence of product recall
- 5.1.3. Opportunities
- 5.1.3.1. Emergence of new technologies and an increase in adoption of S-ICDs and ICDs
- 5.1.3.2. Growing demand of ICDs from emerging economies
- 5.1.4. Challenges
- 5.1.4.1. Limited awareness about sudden cardiac attack in the certain countries
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Implantable Cardioverter Defibrillators Market, by Implantation Location
- 6.1. Introduction
- 6.2. Subcutaneous Implantable Cardioverter Defibrillator
- 6.3. Transvenous Implantable Cardioverter Defibrillator
- 7. Implantable Cardioverter Defibrillators Market, by Product
- 7.1. Introduction
- 7.2. Biventricular/Cardiac Resynchronization Therapy Defibrillators
- 7.3. Dual-Chamber ICD
- 7.4. Single-Chamber ICD
- 8. Implantable Cardioverter Defibrillators Market, by End User
- 8.1. Introduction
- 8.2. Ambulatory Care Unit
- 8.3. Cardiac Center
- 8.4. Electrophysiology Laboratory
- 8.5. Home Care Setting
- 8.6. Hospital & Clinic
- 9. Americas Implantable Cardioverter Defibrillators Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Implantable Cardioverter Defibrillators Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.
- 10. South Korea
- 10.
- 11. Taiwan
- 10.
- 12. Thailand
- 10.
- 13. Vietnam
- 11. Europe, Middle East & Africa Implantable Cardioverter Defibrillators Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.
- 10. Nigeria
- 11.
- 11. Norway
- 11.
- 12. Poland
- 11.
- 13. Qatar
- 11.
- 14. Russia
- 11.
- 15. Saudi Arabia
- 11.
- 16. South Africa
- 11.
- 17. Spain
- 11.
- 18. Sweden
- 11.
- 19. Switzerland
- 11.
- 20. Turkey
- 11.
- 21. United Arab Emirates
- 11.
- 22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. AtaCor Medical, Inc.
- 13.1.3. BIOTRONIK SE & Co KG
- 13.1.4. Boston Scientific Corporation
- 13.1.5. Koninklijke Philips N.V.
- 13.1.6. LivaNova plc
- 13.1.7. Medtronic plc
- 13.1.8. MicroPort Scientific Corporation
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET RESEARCH PROCESS
- FIGURE 2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
- FIGURE 3. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET DYNAMICS
- FIGURE 7. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2023 VS 2030 (%)
- FIGURE 8. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.